 |
| |
|
BC00012
Multiple organ diseased tissue array, 30 cases/60 cores, replaced by MC801
|
|
| Microarray Panel: | Multiple organ diseased tissue microarray, including 30 cases of 11 types of organs carcinoma (brain, breast, colon, esophagus, kidney, liver, lung, stomach, striated muscles, tongue and uterus), duplicate cores per case |
| Cores: | 60 |
|
| Cases: | 30 |
| Layout: | 10 cols × 6 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Cytokeratin (CK) confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bra - Brain,
Bre - Breast,
Col - Colon,
Eso - Esophagus,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Sto - Stomach,
Str - Striated muscles,
Ton - Tongue,
Ute - Uterus
 - Benign tumor,
 - Malignant tumor,
 - Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
Image |
|
A1 |
1 |
F |
55 |
Liver |
Hepatocellular carcinoma |
III |
Malignant |
Image |
|
A2 |
2 |
F |
55 |
Stomach |
Mucous cell carcinoma |
III |
Malignant |
Image |
|
A3 |
3 |
M |
65 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
Image |
|
A4 |
4 |
M |
72 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
Image |
|
A5 |
5 |
F |
29 |
Brain |
Syncytial meningioma |
– |
Benign |
Image |
|
A6 |
6 |
F |
55 |
Uterus |
Adenocarcinoma |
III |
Malignant |
Image |
|
A7 |
7 |
F |
24 |
Uterus |
Alveolar Rhabdomyosarcoma |
– |
Malignant |
Image |
|
A8 |
8 |
M |
37 |
Colon |
Adenocarcinoma |
II |
Malignant |
Image |
|
A9 |
9 |
F |
48 |
Breast |
Infiltrating duct carcinoma |
– |
Malignant |
Image |
|
A10 |
10 |
M |
70 |
Lung |
Adenocarcinoma |
III |
Malignant |
Image |
|
B1 |
11 |
F |
55 |
Liver |
Hepatocellular carcinoma |
III |
Malignant |
Image |
|
B2 |
12 |
F |
55 |
Stomach |
Mucous cell carcinoma |
III |
Malignant |
Image |
|
B3 |
13 |
M |
65 |
Esophagus |
Squamous cell carcinoma |
– |
Malignant |
Image |
|
B4 |
14 |
M |
72 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
Image |
|
B5 |
15 |
F |
29 |
Brain |
Syncytial meningioma |
– |
Benign |
Image |
|
B6 |
16 |
F |
55 |
Uterus |
Inflammatory necrosis tissue |
– |
Malignant |
Image |
|
B7 |
17 |
F |
24 |
Uterus |
Alveolar Rhabdomyosarcoma |
– |
Malignant |
Image |
|
B8 |
18 |
M |
37 |
Colon |
Adenocarcinoma |
II |
Malignant |
Image |
|
B9 |
19 |
F |
48 |
Breast |
Infiltrating duct carcinoma |
– |
Malignant |
Image |
|
B10 |
20 |
M |
70 |
Lung |
Adenosquamous carcinoma |
– |
Malignant |
Image |
|
C1 |
21 |
F |
32 |
Liver |
Hepatocellular carcinoma |
I |
Malignant |
Image |
|
C2 |
22 |
M |
57 |
Stomach |
Adenocarcinoma |
III |
Malignant |
Image |
|
C3 |
23 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
Image |
|
C4 |
24 |
M |
72 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
Image |
|
C5 |
25 |
M |
27 |
Brain |
Fibrous meningioma |
– |
Benign |
Image |
|
C6 |
26 |
F |
50 |
Uterus |
Adenocarcinoma |
I |
Malignant |
Image |
|
C7 |
27 |
M |
7 |
Striated muscles |
Alveolar rhabdomyosarcoma |
– |
Malignant |
Image |
|
C8 |
28 |
M |
62 |
Colon |
Adenocarcinoma |
II |
Malignant |
Image |
|
C9 |
29 |
F |
42 |
Breast |
Fibrofatty tissue |
– |
Malignant |
Image |
|
C10 |
30 |
M |
60 |
Lung |
Adenocarcinoma |
III |
Malignant |
Image |
|
D1 |
31 |
F |
32 |
Liver |
Hepatocellular carcinoma |
I |
Malignant |
Image |
|
D2 |
32 |
M |
57 |
Stomach |
Adenocarcinoma |
III |
Malignant |
Image |
|
D3 |
33 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
Image |
|
D4 |
34 |
M |
72 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
Image |
|
D5 |
35 |
M |
27 |
Brain |
Fibrous meningioma |
– |
Benign |
Image |
|
D6 |
36 |
F |
50 |
Uterus |
Adenocarcinoma |
I |
Malignant |
Image |
|
D7 |
37 |
M |
7 |
Striated muscles |
Alveolar rhabdomyosarcoma |
– |
Malignant |
Image |
|
D8 |
38 |
M |
62 |
Colon |
Adenocarcinoma |
II |
Malignant |
Image |
|
D9 |
39 |
F |
42 |
Breast |
Fibrofatty tissue |
– |
Malignant |
Image |
|
D10 |
40 |
M |
60 |
Lung |
Adenocarcinoma |
III |
Malignant |
Image |
|
E1 |
41 |
M |
63 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
Image |
|
E2 |
42 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Malignant |
Image |
|
E3 |
43 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
II |
Malignant |
Image |
|
E4 |
44 |
M |
54 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
Image |
|
E5 |
45 |
F |
47 |
Brain |
Syncytial meningioma |
– |
Benign |
Image |
|
E6 |
46 |
F |
42 |
Uterus |
Smooth muscle and phlegmasia |
– |
Normal |
Image |
|
E7 |
47 |
M |
38 |
Tongue |
Adenoid cystic carcinoma |
– |
Malignant |
Image |
|
E8 |
48 |
M |
58 |
Colon |
Adenocarcinoma |
I |
Malignant |
Image |
|
E9 |
49 |
F |
65 |
Breast |
Infiltrating duct carcinoma |
– |
Malignant |
Image |
|
E10 |
50 |
M |
57 |
Lung |
Adenocarcinoma |
III |
Malignant |
Image |
|
F1 |
51 |
M |
63 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
Image |
|
F2 |
52 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Malignant |
Image |
|
F3 |
53 |
M |
62 |
Esophagus |
Smooth muscle and phlegmasia |
– |
Malignant |
Image |
|
F4 |
54 |
M |
54 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
Image |
|
F5 |
55 |
F |
47 |
Brain |
Syncytial meningioma |
– |
Benign |
Image |
|
F6 |
56 |
F |
42 |
Uterus |
Smooth muscle and phlegmasia |
– |
Normal |
Image |
|
F7 |
57 |
M |
38 |
Tongue |
Adenoid cystic carcinoma |
– |
Malignant |
Image |
|
F8 |
58 |
M |
58 |
Colon |
Adenocarcinoma |
I |
Malignant |
Image |
|
F9 |
59 |
F |
65 |
Breast |
Infiltrating duct carcinoma |
– |
Malignant |
Image |
|
F10 |
60 |
M |
57 |
Lung |
Adenocarcinoma |
III |
Malignant |
Image |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|
